Heavily shareholder-aligned board and management team completely replaces ReShape team as Vyome prepares for public listing on August 15, 2025
Vyome Therapeutics, Inc., a clinical-stage healthcare company targeting immuno-inflammatory and rare diseases in the US and global markets with large market potential, today announced its post-closing Board of Directors, expected to take control of the ReShape Lifesciences (NASDAQ: RSLS) public entity on Friday, August 15, 2025, which will be renamed Vyome Holdings, Inc. post-closing and trade under the ticker symbol HIND.
The new Vyome board members, which include four Massachusetts Institute of Technology (MIT) alums, are all persons with prior board or executive management experience and are based in the US while having deep ties to the Indian subcontinent and the latest advances in AI.
“We are offering RSLS shareholders significant potential value, and no member of the ReShape board or its management team has been invited to join Vyome Holdings. It is critical to have a board that is fully aligned with all shareholders, and that’s the board we have taking over on Friday. We have a massive vision with a clean company at close – no debt, no toxic structure, all major shareholders locked up, and a world-class team which we look forward to sharing more about in the coming days and weeks,” said Krishna Gupta, Chairman of Vyome Holdings.
The Vyome board will include the following individuals:
- Krishna Gupta (Chairman), MIT engineering/business alum and CEO of Remus Capital – very focused on Vertical AI, applying AI into large traditional industries, including healthcare. He has spent extensive time doing business across India, having been to 22 of its 36 states and union territories.
- Shiladitya Sengupta (Founder), MIT postgrad – serial entrepreneur and reputed professor/researcher at MIT and Harvard Medical School focused on the intersection of medicine and engineering. He was a gold medalist at India’s top medical university (AIIMS).
- Venkat Nelabhotla (Co-founder and CEO), IIM Ahmedabad alum – a seasoned operator with 30+ years of success across pharma, biotech, and CPG industries. He has been a CEO of Emami Limited – a publicly listed company in India, and during his tenure played a pivotal role in significantly increasing the market cap.
- Mohanjit Jolly (Shareholder), MIT alum and Partner of Iron Pillar – a seasoned investor and board member for cutting-edge technology companies. He has been investing in India for nearly 20 years.
- John Tincoff (Shareholder), Georgetown alum, Partner at Remus Capital – has a deep focus on industrial applications with extensive governance experience. He co-manages Remus Capital and leads its industrial AI investing practice, while also having significant board experience across verticals. He spent many years living in South Asia, including significant experience in India.
- Stash Pomichter (Shareholder), MIT engineering dropout and is a member of the Remus Capital team – has a deep focus on cutting-edge AI applications from voice to robotics. He grew up in India.
Explore AITechPark for the latest advancements in AI, IOT, Cybersecurity, AITech News, and insightful updates from industry experts!